30/01/2026
Regenerative medicine is a rapidly evolving field, but not all therapies are produced under the same standards.
In regulated settings, manufacturing follows defined protocols, including:
• controlled production environments
• documented quality control
• batch consistency and traceability
At the same time, it’s important for patients to be aware that regulatory frameworks for stem cell–based therapies differ significantly between countries. What is permitted, controlled, or monitored in one jurisdiction may not be subject to the same oversight in another.
Understanding where and under which regulatory conditions a therapy is produced is a key part of informed decision-making in regenerative medicine.
When biological therapies are manufactured under regulatory oversight, outcomes can be better understood, evaluated, and compared over time.